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In December 2009 an information sheet [1] edited
by WHO reported that, in 2008, 3.6 million women
fell ill with tuberculosis (TB) and 700,000 women
died from TB, including 200,000 with human im-
munodeficiency virus (HIV) and TB. TB is the 3rd
leading cause of death worldwide among women
aged between 15 and 44 years. It should be noted
that this range englobes both the reproductive and
working age. TB is the 4th leading cause of death
among women aged 10-19 years in low income
countries. Once infected, women of reproductive
age are more susceptible to developing TB than
men of the same age. 
TB is the disease of poverty, affecting the most vul-
nerable groups of the world’s population: more
than half of TB-related deaths occur in Asia while
the greatest TB burden as percentage of population
is in Africa. Other factors closely connected to the
social realities of low income countries, like malnu-
trition and food insecurity, can contribute to make
the situation worse and other important factors like
smoking or comorbidities such as diabetes can fur-
ther increase the burden of TB.
The diffusion of the HIV epidemic has provoked a
“feminization” of this infection with a great burden
of HIV-associated TB. The frequent extension of TB
to the reproductive organs in females can be a
cause of infertility. In some countries such as
Pakistan and Afghanistan more women with TB are
detected than men. In some areas of the undevel-
oped world women with TB are discriminated
against and stigmatized by their families and com-
munities. The stigma is always extended to their
children who are marginalized and forced to aban-
don school.
These are some of the critical points that highlight
the importance of looking at TB not only as a mas-
culine disease. We must consider that the points
mentioned above describe a situation where TB is
the leading cause of “healthy years” lost among
women in young age. In this framework, migration
from low-income countries constitutes another dra-
matic aspect of the problem. 
However other co-factors must be investigated, i.e.
the possible presence of anemia that can be caused
both by food restriction and iron deficiency and/or
by parasitic infestations which contribute to micro-
scopic blood loss in the stool [2]. Usually
hypochromic and microcytic anemia coexist, so
that, after having excluded a form of Mediterranean
anemia, a conservative approach based on iron
supplementation or an iron-rich diet is recommend-
ed. Of course any abnormality identified in the
presence of stool ova and parasites needs to be
treated as well. Should this approach fail it is then
necessary to consider also the menstruation histo-
ry and decide if and when to study the iron metab-
olism.
This and other situations co-exist in a context of
deprivation, handicaps and poverty usually local-
ized in specific areas of the world, but they are well
recognizable also in ethnic minorities within
wealthier communities where TB can appear in the
five years after the arrival of immigrants [3]. WHO
document stresses the fact that not only does the
HIV/AIDS epidemic have a disproportionate impact
on minorities, but poverty means as well over-
crowding, poorly ventilated houses, malnutrition,
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social displacement, reduced accessibility to health
care, lack of egalitarian participation in society and
finally a lack of trust in the new system. In these ar-
eas women belong to a category that experiences
longer delays in seeking care and this means in-
creased suffering, more expenses and greater risk
for the community.
Focusing on the overall process of migration [4] dif-
ferent stages can be identified. First, there is a pre-
entry phase where the migrant brings with her/him
the main health profile of the country of origin. The
second phase is often one of transition in which mi-
grants spend their time in places that are not yet the
final destination. In this intermediate phase many
unfavourable conditions can impact negatively on
the migrant’s health [5]. Finally, during the post-en-
try phase new problems arise, such as the process
of adaptation to new modes of work and life that
can negatively influence the migrant’s health. This
novel status is often repulsive for them and migrants
experience real difficulties in finding access to
health facilities.
Migratory TB may therefore be a mirror of all the
problems connected to migration. Amongst other
things the downward trend of incidence is interrupt-
ed by the re-emergence of TB among vulnerable
populations, including those who are migrants from
countries where TB is less well controlled [6-8].
Moreover, as already mentioned, TB in the foreign-
born occurs in younger age and is associated with
higher treatment default and worse outcome [7,8]
and the incidence of multi-drug resistant TB (MDR-
TB) and extensively drug resistant TB (XDR-TB) can
be associated to the migration of people from coun-
tries with high prevalence of these forms.
The role of poverty particularly in a low income
country like India has been well depicted and some
important conclusions have been stressed [9]: three
to four months of work time (the equivalent to 20-
30% of annual household income) are typically lost
due to TB. The cost is higher if patients have delayed
seeking treatment and remain ill longer. The possi-
ble debts as a consequence may trigger sale of as-
sets such as land and livestock causing a much
higher level of poverty. All the family members may
feel the effects of malnutrition, with repercussions
on children’s health. Children may be removed
from school because they have to work to support
the family wages and so about one fifth of school
children in India discontinue their studies, con-
tributing not only to cultural impoverishment but to
perpetuating the vicious cycle of poverty in general.
Women pay also an additional cost connected to
pregnancy and delivery, especially in the peri-par-
tum period. The incidence of TB during pregnancy
is increasing both in developed and developing
countries [10]. 
Tuberculosis is well known to be associated with
immunorestitution disease in HIV patients when a
reversal of immunodepression is achieved with a
recovery of CD4+ lymphocyte counts [11].
Moreover a paradoxical response in the course of
tuberculosis treatment has been reported also in
HIV negative patients [12]. Pregnancy, on the other
hand, might be seen as an immunosuppressive
process aimed to avoid natural rejection of the fe-
tus, and an impairment of lymphocytes activity ex-
pressed by a negative response to intradermo -
reaction with tuberculin has been documented
[13]. After delivery a rebound of lymphocytic activ-
ity is expected as early as 24 h after delivery [13].
Therefore it is possible that in this moment symp-
toms of active disease may arise. Peri-partum tuber-
culosis is defined as the acute deterioration or wors-
ening of clinical symptoms of a pre-existing tuber-
culosis during pregnancy or as the onset of clinical
symptoms of TB within one month after delivery. A
meta-analysis based on the English language litera-
ture extending from 1966 to 2002 [14] showed that
93% of peri-partum TB was located in extra pul-
monary sites, in 69% of cases in the central nervous
system. Despite therapy, 38% of the patients died
and 13.8% had residual functional deficits. The in-
vestigation did not involve the HIV patients. These
disturbing data should prompt the attention of
physicians to differentiate a simple peri-partum
fever from TB. The presence of HIV coinfection sig-
nificantly increases the risk of maternal and infant
disease or death, especially in countries like India
where both infections are highly prevalent [15]. In
this context active screening and targeted isoniazid
preventive therapy among women should be con-
sidered to prevent these dramatic events [15,16]. 
Another point of concern is the presence of extra
pulmonary TB (EPTB) in males and females. In USA,
where many ethnicities are present and many peo-
ple are foreign-born, the whole phenomenon has
been evaluated on the basis of official data from
1993 to 2006 [17]. The authors analyzed both EPTB
and pulmonary TB (PTB), and showed an increased
association between EPTB and female sex, non-
white race and/or ethnicity and foreign-born status.
Other former studies were consistent with these re-
sults [18-20]. Moreover the authors demonstrated a
disproportionately slower decrease in EPTB cases
compared to PTB. EPTB is traditionally considered
non diffusive, but it can be interpreted also as a pos-
sible source of PTB and EPTB as well as of dissem-
inated TB, and contemporary HIV positivity is seen
as a risk factor for disseminated TB [17].
Reconsidering the prevalence of TB in both sexes a
recent report of the WHO [21] affirmed a ratio of
1.9 ± 0.6 between male and females as the world-
wide notification rate, with values as high as 4.7 in
Armenia and ratios below 1 very rare and related to
small populations. This ratio refers to pratically all
the classes of age in adulthood but does not seem
to apply in children or younger adolescents. Apart
from many other factors, amongst which bias of no-
tification should be mentioned, a clear interpreta-
tion of the prevalence in males and women has not
yet been given. Neyrolle and Quintana-Murci [22]
tried to examine the relationship between sex
steroids and the immune response to infections, on
the basis of experimental data. In fact it has been re-






























0 crease in the absolute number of T lymphocytes in
the peripheral lymph nodes [23] and invariant nat-
ural killer T (iNKT) cells from females produce more
interferon (INF)-γ than do the cells from males [22].
Estradiol administration can restore the production
of INF-γ in castrated mice and in those submitted to
genetic ablation in estradiol receptors [23]. Other
models of infection like those caused by
Leishmania and Coxiella suggest that the protection
is higher in females than in males owing to the pos-
sible role of estrogens [24] and estrogens have been
demonstrated to increase the activity of the INF-γ
gene promoter [25]. In fact both innate and im-
mune cells and T lymphocytes can express genetic
receptors for steroid hormones which could modu-
late the response of these cells [26]. 
Examining the maps of the WHO regarding the dis-
tribution of male/female ratios for new smear-posi-
tive TB cases according to age-class, one can ob-
serve that the values tend to decline with the pro-
gression of age and this could indirectly prove that
after menopause TB could become more aggressive
in females. These and other hypotheses need to be
carefully investigated in order to better disclose
many secrets of this disease. 
However, bearing in mind the above information,
we believe that the best conclusion is to return to
the principle expressed in Article 25 of the
Universal Declaration of Human Rights released in
1948: “Everyone has the right to a standard of living
adequate for health and wellbeing including food,
clothing, housing, medical care and necessary so-
cial services and the right to security in the event of
sickness”.
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